A research contact and engagement platform for investigators interested in using mitoquinol in clinical or preclinical research. MCRP provides a direct pathway for academic and clinical researchers to connect with the MitoQ scientific team to discuss the research use of mitoquinol within ethically approved and scientifically rigorous study designs.
Selected published studies shown for research context only
New research explores how an acute dose of MitoQ impacts claudication onset, maximal walking time, and leg artery dilation in patients with Peripheral Artery Disease.
A randomised, double-blind crossover trial assessing whether 6 weeks of Mitoquinol supplementation (20 mg/day) improves endothelial function, reduces aortic stiffness, and attenuates mitochondrial oxidative stress in healthy adults aged 60–79.
A double‑blind trial examining whether 3 weeks of Mitoquinol supplementation during high‑intensity interval training (HIIT) enhances mitochondrial and vascular adaptation without blunting exercise‑induced redox signalling.
